Search
for
Sort by
Research 151–180 of 1000+
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Janus kinase inhibitors for alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- A review of Janus kinase inhibitor use in scarring alopecia
- The role of janus kinases in the treatment of autoimmune skin diseases
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata